Greetings, and welcome to the HeartBeam Fourth Quarter 2025 Financial Results Conference Call. [Operator Instructions]. As a reminder, today's conference is being recorded. Before we begin the formal ...
Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...
He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...
Earnings call Rheinmetall reported FY2025 sales near EUR 10 billion (up 29% YoY, excluding civilian business) and a 33% rise in operating profit to EUR 1.84 billion, with operating margin at 18.5%.
Earnings call CAREL Industries reported FY 2025 revenue of EUR 629 million, up 8.7% YoY (10.6% organic), with Q4 organic growth accelerating to 16.9%. Adjusted EBITDA margin reached 20%, and net ...
Samsung Galaxy S26 Ultra and Buds 4 Pro engineering brief : f/1.4 aperture, AI-ISP selfie, APV 8K codec, Super Wide Woofer, ...
If Maryland had a quirky younger sibling who refused to follow the rules but somehow turned out amazing, it would be Takoma ...
Microsoft has revealed early features of Project Helix, its next-gen Xbox, while confirming plans to send alpha versions of ...
Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits, and ...
A Coma Pattern-Based Autofocusing Method Resolves Bacterial Cold Shock Response at Single-Cell Level
Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...
Researchers developed a machine-learning workflow that predicts how chemical reactions will form specific “handed” versions of molecules—critical for safe and effective drugs. Trained on small ...
Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results